Cost comparison of adverse event management among breast and ovarian cancer patients treated with poly (ADP-ribose) polymerase inhibitors: analysis based on phase 3 clinical trials
Background The economic impact of adverse events (AEs) for poly (ADP-ribose) polymerase inhibitors (PARPis) in ovarian or breast cancer has not been widely evaluated.Objective Compare PARPi-related AE management costs from a US payer perspective.Methods The frequency of treatment-related grade 3-4 A...
-д хадгалсан:
Үндсэн зохиолчид: | , , , , , , , |
---|---|
Формат: | Ном |
Хэвлэсэн: |
Taylor & Francis Group,
2022-12-01T00:00:00Z.
|
Нөхцлүүд: | |
Онлайн хандалт: | Connect to this object online. |
Шошгууд: |
Шошго нэмэх
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|
Интернэт
Connect to this object online.3rd Floor Main Library
Зохиогчийн тэмдэгт: |
A1234.567 |
---|---|
Хуулбар 1 | Бэлэн |